Last reviewed · How we verify
NCT03796520: VASSCA
Validation Study of the Simplified Seizure Classification Algorithm
trial testing EpiPick simplified seizure classification algorithm in Epilepsy in 240 participants. Completed in 31 December 2020.
31 December 2020
Quick facts
| Lead sponsor | Sándor Beniczky |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 240 |
| Start date | 2 June 2019 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 5 locations across Iran, Denmark, United States, Italy |
Drugs / interventions tested
- EpiPick simplified seizure classification algorithm
Conditions studied
- Epilepsy — all drugs for Epilepsy →
Sponsor
Sándor Beniczky
Who can join
Adults 10 to 120, any sex, with Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An algorithm has been developed for simplified classification of epileptic seizures, in order to optimize choice of antiepileptic drugs. The objective of this study was to clinically validate the algorithm.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A web-based algorithm to rapidly classify seizures for the purpose of drug selection.
Beniczky S, Asadi-Pooya AA, Perucca E, Rubboli G, et al · · 2021 · cited 9× · PMID 34420206 · DOI 10.1111/epi.17039 -
Choose Your Own Adventure: Expert Advice at Your Fingertips.
Terman SW. · · 2022 · PMID 35233199 · DOI 10.1177/15357597211062385
Verify or expand the search:
- PubMed search for NCT03796520
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Epilepsy
Currently open trials in the same condition.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07224191 — Hippocampal Oscillations During Exploration · NA · recruiting
- NCT07219407 — A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · recruiting
- NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
- NCT07490769 — Levetiracetam Three Times Daily in Epilepsy · Phase 3 · recruiting
Other Sándor Beniczky trials
Trials by the same sponsor.
- NCT04711070 — Understanding the Mechanisms of Critical Illness Myopathy by Use of a Novel Electrophysiological Method - MVRCs · completed
- NCT04218812 — Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation · NA · unknown
- NCT03560505 — High-resolution Ultrasound in Lower Extremity Nerves and Common Fibular Neuropathies. · completed
- NCT03556449 — High Resolution Ultrasound of Scapulae Alatae - a Prospective Case Control Study · completed
- NCT03664206 — Assessing Motor Neuron Disease Mechanisms by Threshold Tracking Transcranial Magnetic Stimulation and Magnetic Resonance · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03796520 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sándor Beniczky
- Last refreshed: 17 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03796520.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing